Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

OGI stock hub

Organigram Global Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

OGIis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
193.1M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
OGI
In the news

Latest news · OGI

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.4
P25 12.3P50 18.4P75 33.1
Trailing P/E14.6
P25 14.9P50 23.2P75 38.5
ROE4.6
P25 -105.6P50 -46.5P75 -3.1
ROIC-2.9
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All OGI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
213
Groups with data
11
Currency
CAD
Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001620737
Company name
Organigram Global Inc.
Country
Canada
Country code
US
Cusip
68617J100
Employees
1,137
Employees Change
-2%
Employees Change Percent
-0.18
Enterprise value
$233.4M
Exchange
NASDAQ
Financial currency
CAD
First seen
2026-05-09
Industry
Drug Manufacturers - Specialty & Generic
Isin
CA68617J1003
Last refreshed
2026-05-10
Market cap
$193.1M
Market cap category
Micro-Cap
Price
$1.36
Price currency
USD
Rev Per Employee
179,600.75x
Sector
Healthcare
Sic
2834
Symbol
OGI
Website
https://www.organigram.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
6.86%
EV Earnings
17.61x
EV Sales Forward
0.68x
EV/EBITDA
58.9x
EV/Sales
1.14x
FCF yield
-13.98%
Forward P/E
19.4x
P/B ratio
0.62x
P/E ratio
14.58x
P/S ratio
0.95x
PS Forward
0.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-4.26%
EBITDA Margin
1.94%
Gross margin
35.61%
Gross Profit
$72.7M
Gross Profit Growth
82.5%
Gross Profit Growth Q
68.78%
Gross Profit Growth3 Y
87.41%
Gross Profit Growth5 Y
54.73%
Net Income
$13.2M
Net Income Growth Quarters
1%
Net Income Growth Years
2%
Pretax Margin
1.57%
Profit Margin
6.49%
Profit Per Employee
$11,653
ROA
-1.48
ROCE
-2.73
ROE
4.64
ROIC
-2.9
Roic5y
-14.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr10y
-9.04%
Cagr1y
21.45%
Cagr3y
-13.2%
Cagr5y
-34.17%
EPS Growth Quarters
1
EPS Growth Years
2
Revenue Growth
68.55x
Revenue Growth Q
48.7x
Revenue Growth Quarters
5x
Revenue Growth Years
1x
Revenue Growth3 Y
37.63x
Revenue Growth5 Y
25.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.55
Assets
$387M
Cash
$6.1M
Current Assets
$187.7M
Current Liabilities
$68.8M
Debt
$6.2M
Debt EBITDA
$1.29
Debt Equity
$0.02
Equity
$309.6M
Liabilities
$77.5M
Long Term Assets
$199.4M
Long Term Liabilities
$8.7M
Net Cash
$-51,782
Net Cash By Market Cap
$-0.03
Net Debt EBITDA
$0.01
Net Debt Equity
$0
Tangible Book Value
$197.1M
Tangible Book Value Per Share
$1.46
WACC
14.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.73
Inventory Turnover
1.52
Net Working Capital
$113.1M
Quick ratio
0.62
Working Capital
$118.5M
Working Capital Turnover
$1.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-29.05%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-61.23%
1Y total return
21.43%
200-day SMA
1.58
3Y total return
-34.62%
50-day SMA
1.41
50-day SMA vs 200-day SMA
50under200
5Y total return
-87.64%
All Time High
33.76
All Time High Change
-95.97%
All Time High Date
2019-05-21
All Time Low
0.65
All Time Low Change
108.85%
All Time Low Date
2015-09-28
ATR
0.07
Beta
1.91
Ch YTD
-19.05
High
1.39
High52
2.24
High52 Date
2025-12-18
High52ch
-39.29%
Low
1.36
Low52
1.1
Low52 Date
2025-05-08
Low52ch
23.64%
Ma50ch
-3.48%
Premarket Change Percent
0.72
Premarket Price
$1.39
Price vs 200-day SMA
-14.09%
RSI
43.82
RSI Monthly
41.44
RSI Weekly
43.05
Sharpe ratio
0.55x
Sortino ratio
1
Total Return
-29.05%
Tr YTD
-19.05
Tr1m
-0.73%
Tr1w
-4.23%
Tr3m
-11.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Earnings EPS Estimate
$-0.01
Earnings Revenue Estimate
52,060,000x
Earnings Revenue Estimate Growth
13.92x
Operating Income
$-8.7M
Operating margin
-4.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
98,099,477%
Float Percent
72.59%
Net Borrowing
-1,540,543.5
Shares Insiders
0.22%
Shares Institutions
35.96%
Shares Out
135,135,993
Shares Qo Q
2.52%
Shares Yo Y
29.06%
Short Float
3.83%
Short Ratio
8.68
Short Shares
2.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

66
MetricValue
Adjusted FCF
$-29.7M
Average Volume
827,004.2x
Bv Per Share
1.99
CAPEX
$-12.8M
Ch10y
-61.23
Ch1m
-0.73
Ch1w
-4.23
Ch1y
21.43
Ch3m
-11.11
Ch3y
-34.62
Ch5y
-87.64
Ch6m
-11.11
Change
-1.45%
Change From Open
-1.45
Close
1.38
Days Gap
0
Depreciation Amortization
12,691,562.1
Dollar Volume
840,116.9
Earnings Date
2026-05-12
Earnings Time
bmo
EBIT
$-8.7M
EBITDA
$4M
EPS
$0.1
F Score
2
FCF
$-27M
FCF EV Yield
-11.57x
FCF Per Share
$-0.2
Financing CF
28,505,893
Fiscal Year End
September
Founded
2,013
Goodwill
38,421,418.4
Graham Number
2.13916
Graham Upside
57.29
Income Tax
$-10M
Investing CF
-17,399,644
Is Primary Listing
0
Is Spac
No
Last Earnings Date
2026-02-10
Last Report Date
2025-12-31
Last Split Date
2023-07-07
Last Split Type
Reverse
Ma150
1.57
Ma150ch
-13.32%
Ma20
1.44
Ma20ch
-5.29%
Net CF
-4,757,425
Next Earnings Date
2026-05-12
Open
1.38
Optionable
Yes
Position In Range
0
Post Close
1.36
Postmarket Change Percent
0.71
Postmarket Price
$1.37
Ppne
90,327,347.2
Pre Close
1.38
Price Date
2026-05-08
Price EBITDA
$48.74
Ptbv Ratio
0.98
Relative Volume
0.75x
Revenue
204,206,051x
SBC By Revenue
1.31x
Share Based Comp
2,670,809
Tax By Revenue
-4.92x
Tr6m
-11.11%
Volume
617,733
Z Score
0.8
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does OGI pay a dividend?

Capital-return profile for this ticker.

Performance

OGI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+21.4%
S&P 500 1Y: n/a
3Y total return
-34.6%
S&P 500 3Y: n/a
5Y total return
-87.6%
S&P 500 5Y: n/a
10Y total return
-61.2%
S&P 500 10Y: n/a
Ownership

Who owns OGI?

Insider, institutional, and short-interest positioning.

Institutional ownership
+36.0%
Float: +72.6% of shares outstanding
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+3.8%
8.7 days to cover
Y/Y dilution
+29.1%
Negative means the company is buying back shares.
Technical

OGI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.8
Neutral momentum band
Price vs 200-day MA
-14.1%
50/200-day relationship not available
Beta (5Y)
1.91
More volatile than the market
Sharpe ratio
0.55
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About OGI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OGI stock rating?

Organigram Global Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OGI analysis?

The full report lives at /stocks/OGI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OGI?

The latest report frames OGI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OGI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.